SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Systems Oncology, LLC (“SO”) and The Pritzker Organization, LLC (“TPO”) announced today that Pritzker Family Business Interests advised by TPO have invested in the first closing of SO’s Series B round. The funding will be used to invest in both discovery research and pre-clinical development to evolve SO’s rapidly expanding pipeline of innovative cancer therapeutics.

Continue reading→

Developed by a research team at the University of Arizona College of Medicine – Phoenix, the self-collection device quickly can evaluate radiation exposure and help triage emergency treatment in the event of a nuclear attack or accident.Continue reading→

TUCSON, Ariz. and AUSTIN, Texas, October 15, 2019 — The Critical Path Institute (C-Path) and CDISC are pleased to announce the release of a global Foundational Standard that describes how to represent data for the natural history and efficacy studies conducted in animals submitted to applications under the U.S. Food and Drug Administration (FDA) regulations commonly known as the Animal Rule. The Animal Rule provides a regulatory mechanism for the approval of drugs and licensure of biological products when human efficacy studies are not ethical or feasible.Continue reading→

TUCSON, Ariz., Oct. 15, 2019 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it will begin taking orders for its new 2,002-gene HTG EdgeSeq Autoimmune Panel, which is expected to be commercially available for purchase in kit form or as a service in HTG’s VERI/O laboratory at the end of October 2019. The HTG EdgeSeq Autoimmune Panel provides a comprehensive look into immune system dysfunction, discovery of new biomarkers and the discovery of predictive signatures of drug response in the autoimmune space. The panel is designed to address many questions around autoimmune disorders, which are chronic and often difficult to accurately diagnose. Autoimmune disorders represent a large and growing market, with annual direct U.S. healthcare costs for the treatment of autoimmune disorders being nearly double the direct U.S. healthcare costs for the treatment of cancer, and several of the largest selling pharmaceutical products are targeted towards autoimmune diseases.Continue reading→

Blood pressure medication can prevent fluid retention and muscle wasting in heart failure.

Continue reading→

TUCSON, Ariz., Oct. 10, 2019 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today provided an update regarding its ongoing efforts related to the development, manufacture and commercialization of companion diagnostic assays.Continue reading→

“Leading Women – Biotech and Beyond” has gained a reputation as a smart and sassy way to kick off Arizona Biosciences Week. Gathered high in the penthouse boardroom of Perkins Coie, an international law firm, some 40 women – and a few brave men – come together to share support and stories.

“I love to come to this event,” said one attendee. “When smart, savvy and successful woman come together, they are able to be truly authentic. The storytelling and laughter make for exhilarating evening.”Continue reading→

“The city of Phoenix has made smart investments into building its bioscience infrastructure and it is paying off in economic impact, new company attraction, exciting job opportunities for residents and most importantly, medical insights that benefit people with health challenges who need help today.” said Joan Koerber-Walker, president and CEO of the Arizona Bioindustry Association.

“One visible example of the impact of these investments is the Phoenix Biomedical Campus, which includes eight facilities and spans 30 acres in the city center. It is a place were we’re training medical professionals, treating patients with life threatening diseases, and creating a home for companies that are working to develop new cures.”Continue reading→